Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275769 · ClinicalTrials.gov registry record · NA
CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse
A NA study of Bradycardia and Arrhythmia, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 860
- Enrollment target
- 20
- Study locations
NCT00275769: Completed NA study of Bradycardia and Arrhythmia, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00275769 is a NA study of Bradycardia and Arrhythmia that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 860 participants, below the 4,383-participant average among 29 other Bradycardia trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275769, a NA study of Bradycardia and Arrhythmia, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 860 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study compares the pacemaker's automatic pacing threshold measurements to the manual measurements conducted by a health care provider.
Conditions Studied
Interventions
- DEVICE Pacemaker
Study Locations (20)
California
- - Fullerton
- - Oceanside
- - Redondo Beach
- - Stanford
Florida
- - Brandon
- - Daytona Beach
- - Orlando
- - Sarasota
Alabama
- - Anchorage
- - Mobile
Georgia
- - Athens
- - Gainsville
Illinois
- - Chicago
- - Peoria
Colorado
- - Colorado Springs
District of Columbia
- - Washington D.C.
Iowa
- - Des Moines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 860 participants |
| Start Date | 2004-03 |
| Est. Completion | 2006-09 |
| Phase | NA |
What the finished NCT00275769 record still lists
NCT00275769 is an interventional study that assigns participants to a tested intervention. The registered 860 participants enrollment target is mid-sized for trials with a published cap, below the 4,383-participant average among 29 other Bradycardia trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Pacemaker is the first listed.
NCT00275769 names 20 study sites across 11 states, led by California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT00275769 about?
NCT00275769 is a clinical study titled "CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse". This study compares the pacemaker's automatic pacing threshold measurements to the manual measurements conducted by a health care provider.
What is the current status of trial NCT00275769?
This trial is currently completed. It is a NA study. The enrollment target is 860 participants. The study started on 2004-03. Estimated completion is 2006-09.
What conditions does trial NCT00275769 study?
This clinical trial studies the following conditions: Bradycardia, Arrhythmia.
What interventions are being tested in trial NCT00275769?
The interventions under investigation include: Pacemaker (DEVICE).
Who is sponsoring clinical trial NCT00275769?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00275769 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00275769's enrollment target sits among peer trials
860 15th of 29 higher than 15 of 29 other Bradycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
RECRUITING · NA
-
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
ACTIVE NOT RECRUITING · NA
-
Aveir DR i2i Study
ACTIVE NOT RECRUITING · NA
-
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
ACTIVE NOT RECRUITING · NA
-
EMRI SureScan™ Clinical Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
- NCT06161025 · 860 participants · Phase 2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- NCT06541574 · 860 participants · Phase 2
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia